Dopamine D2/3 occupancy of ziprasidone across a day: a within-subject PET study-Reference-Cited by-同舟云学术

Dopamine D2/3 occupancy of ziprasidone across a day: a within-subject PET study

Published:2013-02-17 Issue:1 Volume:228 Page:43-51
ISSN:0033-3158
Container-title:Psychopharmacology
language:en
Short-container-title:Psychopharmacology

Author:

Suzuki Takefumi,Graff-Guerrero Ariel,Uchida Hiroyuki,Remington Gary,Caravaggio Fernando,Borlido Carol,Pollock Bruce,Mulsant Benoit,DeLuca Vincenzo,Ismail Zahinoor,Mamo David

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s00213-013-3012-1.pdf

Reference43 articles.

1. Bench C, Lammerstma A, Grasby P, Dolan R, Frackowiak R, Warrington S, Boyce M, Gunn K, Brannick L (1996) The time course of binding to striatal dopamine D < sub > 2 receptors by the neuroleptic ziprasidone (CP-88,059–01) determined by positron emission tomography. Psychopharmacology 124:141–147

2. Bench C, Lammertsma A, Dolan R, Grasby P, Warrington S, Gunn K, Cuddigan M, Turton D, Osman S, Frackowiak R (1993) Dose dependent occupancy of central dopamine D2 receptors by the novel neuroleptic CP-88,059–01: a study using positron emission tomography and 11C-raclopride. Psychopharmacology 112:308–314

3. Caley CF, Cooper CK (2002) Ziprasidone: the fifth atypical antipsychotic. Ann Pharmacother 36:839–851

4. Cherma MD, Reis M, Hagg S, Ahlner J, Bengtsson F (2008) Therapeutic drug monitoring of ziprasidone in a clinical treatment setting. Ther Drug Monit 30:682–688

5. Citrome L (2009) Using oral ziprasidone effectively: the food effect and dose–response. Adv Ther 26:739–748

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: Focus on antipsychotics;The World Journal of Biological Psychiatry;2024-09

2. Medications for Psychosis: Dopamine Blockers and Dopamine Partial Agonists (Antipsychotics);Tasman’s Psychiatry;2024

3. Update Lessons from Positron Emission Tomography Imaging Part I: A Systematic Critical Review on Therapeutic Plasma Concentrations of Antipsychotics;Therapeutic Drug Monitoring;2023-11-27

4. Medications for Psychosis: Dopamine Blockers and Dopamine Partial Agonists (Antipsychotics);Tasman’s Psychiatry;2023

5. Beyond monoamines: I. Novel targets and radiotracers for Positron emission tomography imaging in psychiatric disorders;Journal of Neurochemistry;2022-05-10